2025
peer-review
OpenAlex
Fabiana de Lima Vazquez, Lina Carvalho, Anna Luiza Silva Almeida Vicente, Welinton Yoshio Hirai et autres
Accès ouvert
2025
article
OpenAlex
Fabiana de Lima Vazquez, Anna Luiza Silva Almeida Vicente, Welinton Yoshio Hirai, Carolina Lourenço Conceição et autres
IntroductionLung cancer is the leading cause of cancer-related death. Screening for lung cancer using low dose computed tomography (LDCT) significantly reduces lung cancer mortality. However, their implementations must be cost-effective while also prioritizing inclusivity and equity. In this context, telemedicine has emerged …
br, pt
(code pays fourni par la source)
2025
peer-review
OpenAlex
Fabiana de Lima Vazquez, L. Carvalho, Anna Luiza Silva Almeida Vicente, Welinton Yoshio Hirai et autres
Accès ouvert
2024
article
OpenAlex
Rodrigo de Oliveira Cavagna, Flávia Escremim de Paula, Gustavo Nóriz Berardinelli, Murilo Bonatelli et autres
br, pt
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Rodrigo de Oliveira Cavagna, Flávia Escremim de Paula, Gustavo Nóriz Berardinelli, Murilo Bonatelli et autres
INTRODUCTION: Lung cancer in never-smoker (LCINS) patients accounts for 20% of lung cancer cases, and its biology remains poorly understood, particularly in genetically admixed populations. We elucidated the molecular profile of driver genes in Brazilian LCINS. METHODS: The mutational and gene fusion …
br, es, pt
(code pays fourni par la source)
2023
conference-abstract
OpenAlex
Ludmila Pereira Barbosa Dos Santos, Fabiana de Lima Vazquez, Letícia Ferro Leal, José Elias Miziara et autres
Introduction: Lung cancer screening has proven to reduce lung cancer deaths in high income countries. Mobile units (MU) have successfully employed lung cancer screening to increase recruitment of high-risk subjects. Although MU are able to achieve hard-to-reach populations, explaining exam results might …
br
(code pays fourni par la source)
2023
conference-abstract
OpenAlex
Rodrigo Sampaio Chiarantano, Fabiana de Lima Vazquez, Ludmila Barbosa Pereira Dos Santos, José Elias Miziara et autres
Introduction: Lung cancer screening (LCS) has been shown to reduce lung cancer deaths in high-risk subjects of high-income countries. Implementation of LCS programs can be a challenge when resources are limited. Barretos Cancer Hospital implemented a LCS program using a mobile unit …
br
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Edmundo Carvalho Mauad, Gérson Mucillo, Miguel Aboriham Gonçalves, José Elias Miziara et autres
Os autores, preocupados com gastos não médicos como transporte, alimentação, hospedagem, etc., de pacientes com câncer nos seus deslocamentos até o Hospital São Judas Tadeu, Barretos, SP, resolveram fazer um estudo deste problema. Um questionário foi aplicado a 114 pacientes que faziam …
br
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Rodrigo de Oliveira Cavagna, Icaro Alves Pinto, Flávia Escremim de Paula, Gustavo Nóriz Berardinelli et autres
INTRODUCTION: TP53 is the most frequently mutated gene in lung tumors, but its prognostic role in admixed populations, such as Brazilians, remains unclear. In this study, we aimed to evaluate the frequency and clinicopathological impact of TP53 mutations in non-small cell lung …
br, es, pt
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Rodrigo Sampaio Chiarantano, Fabiana de Lima Vazquez, Alexánder Franco, Larissa Cristina Ferreira et autres
INTRODUCTION: Lung cancer is the deadliest cancer worldwide and in Brazil. Despite strong evidence, lung cancer screening by low-dose computed tomography (LDCT) in high-risk individuals is far from a reality in many countries, particularly in Brazil. Brazil has a universal public health …
br, pt
(code pays fourni par la source)
Accès ouvert
2022
conference-abstract
OpenAlex
Beatriz Garbe Zaniolo, Rodrigo de Oliveira Cavagna, Flávia Escremim de Paula, Iara Viana Vidigal Santana et autres
Introdução: O gene KRAS encontra-se mutado em aproximadamente 24% dos casos de câncer de pulmão de células não pequenas (NSCLC). Recentemente, novas drogas alvo, Sotorasib/Adagrasib, foi aprovada para pacientes carreadores da mutação p.(Gly12Cys) em KRAS. A relação deste oncogene com características clinicopatológicas …
br
(code pays fourni par la source)
Accès ouvert
2021
conference-abstract
OpenAlex
Rodrigo de Oliveira Cavagna, Flávia Escremim de Paula, Gustavo Nóriz Berardinelli, Débora Sant'Anna et autres
br, us
(code pays fourni par la source)